Bildnachweis: Sachs Associates.
For the first time since the pandemic started, Sachs Associates are pleased to announce that they will be delivering the 15th ELSF as a hybrid event, with 2 days taking place in-person back in the Hilton Zurich Airport Hotel. The physical programme will consist of the usual physical panels and keynotes, which will be broadcasted live to the virtual audience. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. The in-person event will be followed by an additional two days of virtual meetings available through the audio/video online meeting system.
Back for its 15th Annual Edition, this global bio-pharma industry event will address the main challenges for 2022, including investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors.
The main programme for the 15th Annual ELSF is spread throughout 2 days (1st-2nd of March) and will include BioCapital & Investment Day and Bio-Pharma Partnering & Therapeutics Day. The two days will feature more than 12 hours of high-level speeches and panel discussions. In addition, there is a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities.